Optimi Health Corp. (OPTH)
NASDAQ: OPTH · Real-Time Price · USD
2.250
+0.070 (3.21%)
Nov 13, 2026, 4:00 PM EST - Market closed
Optimi Health Revenue
Optimi Health had revenue of 140.20K CAD in the quarter ending June 30, 2026, a decrease of -28.61%. This brings the company's total for the last twelve months to 175.67K, down -67.95% year-over-year. In the fiscal year ending September 30, 2025, Optimi Health had annual revenue of 426.30K with 9.35% growth.
Revenue (ttm)
175.67K CAD
Revenue Growth
-67.95%
P/S Ratio
101.94
Revenue / Employee
n/a
Employees
n/a
Market Cap
13.02M USD
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Sep 30, 2025 | 426.30K | 36.45K | 9.35% |
| Sep 30, 2024 | 389.85K | 208.76K | 115.28% |
| Sep 30, 2023 | 181.09K | 100.37K | 124.35% |
| Sep 30, 2022 | 80.72K | - | - |
| Sep 30, 2021 | - | - | - |
| Sep 30, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. It does not take any expenses into account and is therefore different from profits.
Related Stocks
| Company Name | Revenue |
|---|---|
| Rockwell Medical | 69.39M |
| Aytu BioPharma | 57.57M |
| Biofrontera | 46.18M |
| Sonoma Pharmaceuticals | 23.49M |
| SCYNEXIS | 18.88M |
| Universe Pharmaceuticals INC | 17.74M |
| China Pharma Holdings | 3.91M |
| TherapeuticsMD | 3.27M |
OPTH News
- 18 days ago - Optimi Health Establishes Optimi Australia Pty Ltd as Dedicated Distribution and Business Development Entity - Financial Post
- 18 days ago - Optimi Health Establishes Optimi Australia Pty Ltd as Dedicated Distribution and Business Development Entity - GlobeNewsWire
- 24 days ago - Optimi Health Completes MDMA Production For Phase 3 PTSD Trial And International Supply - Nasdaq
- 24 days ago - Optimi Health Completes MDMA Production for Phase 3 PTSD Trial in Canada, MAPS Trial in Israel and Commercial Supply in Australia - Financial Post
- 24 days ago - Optimi Health Completes MDMA Production for Phase 3 PTSD Trial in Canada, MAPS Trial in Israel and Commercial Supply in Australia - GlobeNewsWire
- 4 weeks ago - Optimi Health Transcript: The ThinkEquity Conference - Transcripts
- 5 weeks ago - Optimi Health to Present at the ThinkEquity Conference - Financial Post
- 5 weeks ago - Optimi Health to Present at the ThinkEquity Conference - GlobeNewsWire